Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer
Human Pathology, ISSN: 0046-8177, Vol: 44, Issue: 8, Page: 1457-1464
2013
- 20Citations
- 47Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations20
- Citation Indexes20
- 20
- CrossRef19
- Captures47
- Readers47
- 47
Article Description
Pathologists have recognized breast cancer heterogeneity for decades, but its causes were unknown. In recent years, basic science and translational studies have demonstrated that cancer stem cells contribute to the heterogeneous histologic and functional characteristics of breast cancer. Even more recently, the ability of breast epithelial cells to undergo an epithelial-to-mesenchymal transition has been linked to the acquisition of stem cells properties and enhanced tumor invasion, metastasis, and resistance to available treatments. The stem cells and cells undergoing epithelial-to-mesenchymal transition are attractive targets for therapy and breast cancer prevention. Despite current challenges, their identification in breast tissue samples would enable pathologists to discover and validate prognostic and predictive markers as well as identify markers of increased risk for breast cancer.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0046817713000257; http://dx.doi.org/10.1016/j.humpath.2013.01.005; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84880326175&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23574782; https://linkinghub.elsevier.com/retrieve/pii/S0046817713000257; http://www.humanpathol.com/article/S0046-8177(13)00025-7/abstract; http://linkinghub.elsevier.com/retrieve/pii/S0046817713000257; https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=http%3A%2F%2Fwww.humanpathol.com%2Farticle%2FS0046-8177%2813%2900025-7%2Fabstract&rc=0&code=yhupa-site; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.humanpathol.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaankmpuM4Yj2b2-QSTxv%2526MAID%253D%25252B2vlLSzM5lPO5191f%25252B%25252Fd3A%25253D%25253D%2526SERVER%253DWZ6myaEXBLHj3ZzqSv9HPw%25253D%25253D%2526ORIGIN%253D166743305%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.humanpathol.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaankmpuM4Yj2b2-QSTxv%2526MAID%253D%25252B2vlLSzM5lPO5191f%25252B%25252Fd3A%25253D%25253D%2526SERVER%253DWZ6myaEXBLHj3ZzqSv9HPw%25253D%25253D%2526ORIGIN%253D166743305%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.humanpathol.com%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3DaaankmpuM4Yj2b2-QSTxv%26MAID%3D%252B2vlLSzM5lPO5191f%252B%252Fd3A%253D%253D%26SERVER%3DWZ6myaEXBLHj3ZzqSv9HPw%253D%253D%26ORIGIN%3D166743305%26RD%3DRD&acw=&utt=; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.humanpathol.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253Daaa_7fsyCzQ04-ZPgjnxv%2526MAID%253DArEdGYcIXsdYInKv9%25252B9EHA%25253D%25253D%2526SERVER%253DWZ6myaEXBLF%25252FdY29RpN4fA%25253D%25253D%2526ORIGIN%253D377086444%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.humanpathol.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253Daaa_7fsyCzQ04-ZPgjnxv%2526MAID%253DArEdGYcIXsdYInKv9%25252B9EHA%25253D%25253D%2526SERVER%253DWZ6myaEXBLF%25252FdY29RpN4fA%25253D%25253D%2526ORIGIN%253D377086444%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.humanpathol.com%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3Daaa_7fsyCzQ04-ZPgjnxv%26MAID%3DArEdGYcIXsdYInKv9%252B9EHA%253D%253D%26SERVER%3DWZ6myaEXBLF%252FdY29RpN4fA%253D%253D%26ORIGIN%3D377086444%26RD%3DRD&acw=&utt=
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know